Klotho基因rs495392多态性与CKD患者动脉粥样硬化进展的关联
本研究基于NEFRONA队列1439例CKD患者的多中心前瞻性观察数据,基线及24个月时对10个动脉区域行超声评估,采用多因素logistic回归分析Klotho基因11个SNP与动脉粥样硬化进展的关联。结果显示仅rs495392与进展独立显著相关,携带一个T等位基因进展风险降低30%,两个T等位基因降低近50%。
要点
- Klotho基因rs495392的T等位基因与CKD患者动脉粥样硬化进展风险降低相关。
- 携带一个T等位基因进展风险降低30%,两个T等位基因降低近50%。
- 其余10个Klotho基因SNP与动脉粥样硬化进展无独立显著关联。
核心结论
- Klotho基因rs495392的T等位基因与CKD患者动脉粥样硬化进展风险降低独立相关。
研究设计与样本
- 多中心前瞻性观察性研究,纳入NEFRONA队列1439例CKD患者。
- 基线及24个月时对10个动脉区域行颈动脉和股动脉超声评估。
- 对Klotho基因11个SNP行基因分型,采用多因素logistic回归分析其与动脉粥样硬化进展的关联。
主要发现
- 双变量分析中11个SNP均与动脉粥样硬化斑块患病率无关联。
- rs495392、rs562020和rs567170在双变量分析中与动脉粥样硬化进展相关。
- 多因素校正后仅rs495392与进展独立显著相关,携带一个T等位基因进展风险降低30%,两个T等位基因降低近50%。
关键数值与推荐
- 动脉粥样硬化进展定义为有斑块的动脉区域数量增加。
- 携带一个T等位基因的进展比值比降低30%,携带两个T等位基因降低近50%。
临床怎么用
- rs495392的T等位基因可作为CKD患者动脉粥样硬化进展风险分层的潜在遗传标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prevalence of atherosclerotic cardiovascular disease and its rate of progression are higher in patients with chronic kidney disease (CKD) compared with the general population. Mineral metabolism parameters have been shown to be involved in the increased velocity of atheromatosis progression. The aim of this study is to determine the role of 11 single-nucleotide polymorphisms (SNPs) of the Klotho gene on the rate of atherosclerosis progression in CKD. METHODS: This was a multicentre, prospective, observational study of 1439 CKD patients from the NEFRONA cohort. Carotid and femoral ultrasounds were performed at baseline and after 24 months in 10 arterial territories. Progression of atheromatosis was defined as an increase in the number of territories with plaque. Genotyping of 11 SNPs of the Klotho gene was performed and its association with atheromatosis progression was determined by multivariate logistic regression. RESULTS: Bivariate analysis showed that none of the 11 SNPs was associated with atheroma plaque prevalence, but 3 of them (rs495392, rs562020 and rs567170) showed association with atheromatosis progression. The multivariate analysis revealed that only rs495392 showed a statistically significant association with atheromatosis progression, after adjustment for several parameters known to affect it in CKD patients. Thus, the presence of one allele T was associated with a reduction of 30% of the odds of progression, whereas the presence of the two T alleles was associated with a decrease close to 50%. CONCLUSIONS: The presence of the allele T of the SNP rs495392 of the Klotho gene is associated with a decrease in the odds of progression of atheromatosis in CKD patients.
引用
- Valdivielso JM, Bozic M, Galimudi RK, et al. Association of the rs495392 Klotho polymorphism with atheromatosis progression in patients with chronic kidney disease. Nephrol Dial Transplant. 2019. PMID: 30010839. doi:10.1093/ndt/gfy207
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。